NICEVIVA
MONOGRAPH SPEC LATEST 2027

Silica (Hair/Nails)

SKIN HAIR · Evidence Monograph

Silica (Hair/Nails) is an evidence-graded skin hair monograph evaluated across 24 peer-reviewed PubMed studies (0 meta-analyses, 0 systematic reviews, and 0 randomized controlled trials, encompassing n = 668 cumulative participants). Current clinical evidence is rated GRADE Low (2.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

Evidence Grade (GRADE) Low (2.0 / 4.0)
Indexed PubMed Studies 24 Studies
Meta-Analyses · Reviews 0 Meta · 0 Systematic Reviews
Randomized Trials (RCT) 0 RCTs (0 Double-Blind)
Cumulative Participants n = 668
Reported Trial Dosages 0.02 µg · 0.35 µg · 0.18 µg
Trial Duration Range 7 days · 3 days · 10 weeks
Reading Time ~12 min
RECOMMENDED FOR Clinical Indication

Evidence Supports Supplementation When:

  1. 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 24 indexed PubMed studies, GRADE Low).
  2. 02 Adults matching clinical trial dosing protocols (0.02 µg · 0.35 µg · 0.18 µg) over a structured 7 days evaluation window.
  3. 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
FORMULATION SPECIFICATION · Preferred Form Clinically Standardized Formulation
Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.
CLINICAL RESPONSE · Body Signal Check
Expected Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.
Dose Adjustment Signal: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.
CHRONOBIOLOGY · Optimal Dosing Window PM 12:30
With Breakfast or Lunch
Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.
Primary Clinical Endpoints & Physiological Biomarkers Studied Based on Indexed PubMed Trials
alopecia (PubMed clinical endpoint)
hair (PubMed clinical endpoint)
immune (PubMed clinical endpoint)
skin (PubMed clinical endpoint)
01

What Is Silica (Hair/Nails) & Why Does Form Matter?

Silica (Hair/Nails) is classified under SKIN HAIR and has been investigated across 24 peer-reviewed PubMed publications for its role in targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

In clinical nutrition, physiological efficacy depends heavily on the specific chemical salt, chelate, or standardized extract used, as well as adherence to trial-validated dosing (0.02 µg, 0.35 µg, 0.18 µg).

02

Who Benefits Most & Common Depletion Factors

Suboptimal status or increased physiological demand for Silica (Hair/Nails) frequently arises from restrictive dietary patterns, age-related declines in gastrointestinal absorption, chronic metabolic stress, or medication-induced nutrient depletion.

Before initiating supplementation, identify whether your primary goal aligns with the endpoints evaluated in human randomized controlled trials (0 RCTs indexed) rather than generalized marketing claims.

03

Physiological Mechanism of Action

Within human physiology, Silica (Hair/Nails) acts on pathways governing targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support. Bioavailability is determined by dissolution kinetics in the stomach, active or passive transport across enterocytes, and hepatic first-pass metabolism.

Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

04

PubMed Clinical Evidence & GRADE Evaluation

NICEVIVA assigns Silica (Hair/Nails) an overall evidence rating of GRADE Low (2.0 / 4.0) based on 24 PubMed studies: 0 meta-analyses, 0 systematic reviews, and 0 randomized controlled trials (0 double-blind, n = 668 total participants).

Representative peer-reviewed findings include: • PMID:39844356 (2025) — "Global Delphi consensus on treatment goals for generalized pustular psoriasis." (avoiding hair and/or nail loss to improve QoL), reflect the complexity of assessing treatment goals and emphasize the need for a patient-centred approach.) • PMID:41018308 (2025) — "Assessing the Significance and Awareness of Oral Collagen in Enhancing Health and Beauty Among Consumers in Saudi Arabia: A Cross-Sectional Study." (Improved public awareness and further research are recommended to optimize safe and effective use.) • PMID:40237936 (2025) — "Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential." (A significant challenge lies in managing autoimmune disorders with unknown origins that stem from the reactivation of the immune system.)

05

Formulation Selection, Dosing & Chronobiology

Recommended Formulation: Clinically Standardized Formulation. Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

Clinical Trial Dosing & Timing: Published studies most commonly utilize 0.02 µg · 0.35 µg · 0.18 µg · 30 mg over 7 days · 3 days · 10 weeks · 14 days. Optimal timing window: PM 12:30 · With Breakfast or Lunch (Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.).

06

Body Response Monitoring & Dose Adjustment

Expected Positive Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.

Adjustment & Discontinuation Signals: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.

07

Prescription Drug Interactions & Contraindications

No major high-risk prescription contraindications are flagged in the primary index for Silica (Hair/Nails), but divalent minerals, fat-soluble compounds, and botanical extracts can still alter absorption or CYP450 metabolism of concurrent medications.

Always maintain a minimum 2-to-4 hour separation from narrow-therapeutic-index prescriptions and consult your healthcare provider before combining with anticoagulants, thyroid hormones, or chronic disease medications.

08

4 Essential Safety Rules Before & After Dosing

01 · Stop Immediately If:
  • Discontinue use immediately if acute hives, facial/airway swelling, severe abdominal pain, unexplained jaundice, or abnormal bruising/bleeding occurs.
  • Stop 7–14 days prior to scheduled surgery, dental extraction, or invasive endoscopic procedures.
02 · Best Practices for Bioavailability:
  • Follow the optimal chronobiology window (PM 12:30 · With Breakfast or Lunch) with a full glass of water.
  • Stay within clinically studied daily dosages (0.02 µg · 0.35 µg · 0.18 µg) and re-evaluate efficacy after 7 days.
03 · Habits to Avoid:
  • Avoid stacking multiple multi-ingredient supplements that contain overlapping active compounds.
  • Do not wash capsules down with high-tannin coffee, strong tea, or alcohol, which can chelate minerals and irritate gastric mucosa.
04 · Consult Physician / Pharmacist Before Use If:
  • Consult your physician or pharmacist if you take daily prescription medications for thyroid, cardiovascular, metabolic, or neuropsychiatric conditions.
  • Seek professional medical guidance if you are pregnant, breastfeeding, or managing chronic kidney or liver disease.
09 · PUBMED CLINICAL STUDIES

Indexed PubMed Clinical Studies & Abstracts (24 Studies) · 4 Quantitative Analyses

01
CLINICAL STUDY The British journal of dermatology (2025) PMID: 39844356 ↗
Global Delphi consensus on treatment goals for generalized pustular psoriasis.
Clinical Trial Synthesis 2025 Clinical Study published in The British journal of dermatology. Key conclusion: avoiding hair and/or nail loss to improve QoL), reflect the complexity of assessing treatment goals and emphasize the need for a patient-centred approach.
View Original PubMed Abstract ↓

BACKGROUND: Generalized pustular psoriasis (GPP) is a chronic, systemic, neutrophilic inflammatory disease. A previous Delphi panel established areas of consensus on GPP, although patient perspectives were not included and aspects of treatment goals remained unclear. OBJECTIVES: To identify and achieve consensus on refined, specific treatment goals for GPP treatment via a Delphi panel with patient participation. METHODS: Statements were generated based on a systematic literature review and revised by a Steering Committee. Statements were categorized into overarching principles, and short- and long-term treatment goals. A global panel of 30 dermatologists and 3 patient representatives voted in agreement or disagreement with each statement. Consensus was defined as ≥ 80% approval by the panellists. RESULTS: Consensus was reached in the first round of voting and ≥ 90% agreement was reached for 23 of 26 statements. In summary, GPP requires a timely, tailored treatment plan, co-developed by patients and physicians, that involves a multidisciplinary approach and addresses the complexity, heterogeneity and chronicity of the disease. Short-term treatment goals should include pustule clearance within 7 days and prevention of pustule recurrence, reduction of cutaneous symptom burden (-4 or more points on the Itch and Skin Pain Numeric Rating Scale), improvement in systemic symptoms (e.g. resolution of fever within 3 days of treatment initiation and reduced fatigue), prevention of life-threatening complications and progressive improvement of inflammatory biomarkers. In patients with comorbid psoriatic diseases, treatment decisions should prioritize GPP. Long-term treatment goals should include minimizing disease activity through flare prevention and symptom control between flares, sustained disease control, management of comorbidities and improvement in quality of life (QoL). Small differences in perception between patients and physicians regarding the importance of certain treatment goals (e.g. avoiding hair and/or nail loss to improve QoL), reflect the complexity of assessing treatment goals and emphasize the need for a patient-centred approach. CONCLUSIONS: In the first

02
CLINICAL STUDY Cureus (2025) PMID: 41018308 ↗
Assessing the Significance and Awareness of Oral Collagen in Enhancing Health and Beauty Among Consumers in Saudi Arabia: A Cross-Sectional Study.
Clinical Trial Synthesis 2025 Clinical Study published in Cureus involving n = 171 participants; statistical significance reported at p = 0.033. Key conclusion: Improved public awareness and further research are recommended to optimize safe and effective use.
View Original PubMed Abstract ↓

Background Oral collagen supplements have become increasingly popular in Saudi Arabia, as they are widely recognized for their significant benefits to skin health, joint support, and overall wellness. This study aimed to evaluate the significance of oral marine collagen in enhancing health and beauty among Saudi consumers. Method A cross-sectional survey involving 171 participants was conducted to evaluate the effectiveness, usage, side effects, and reasons for discontinuation of the product. Data were analyzed using descriptive statistics, Chi-square tests, and a logistic regression model using SPSS version 29.0.0 (IBM Corp., Armonk, NY). Results Among 171 participants, the majority were women (153, 89.5%) and aged 20-30 years (78, 45.6%). Collagen use was reported by 56 (32.7%), mainly for strengthening hair/nails (42, 75%) and improving skin (40, 71.4%). Reported improvements included hair/nails (13, 23.2%), with 25 (44.6%) experiencing some improvement; skin (13, 23.2%), with 24 (42.9%) experiencing some improvement; joint pain (12, 21.4%), with 22 (39.3%) experiencing some improvement. Powder (45, 80.4%) was the most used form. Users of collagen for 4-8 weeks had significantly greater hair/nail improvement (73.7% versus 26.3%, p=0.033) and lower early discontinuation (16.7% versus 50.0%, p=0.010). Side effects were reported by 32 (57.1%), with gastrointestinal (GIT) symptoms in 18 (32.1%). Sleep duration improved post-supplementation, but not significantly (p=0.175). Age was the only significant predictor of collagen benefit (p=0.002), with younger participants more likely to report positive outcomes. Conclusions This study shows that oral collagen use is associated with modest improvements in hair, skin, joint comfort, and sleep, particularly with consistent use over 4-8 weeks. Younger individuals experienced greater benefits. However, side effects and early discontinuation were common. Improved public awareness and further research are recommended to optimize safe and effective use.

03
CLINICAL STUDY Journal of physiology and biochemistry (2025) PMID: 40237936 ↗
Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential.
Clinical Trial Synthesis 2025 Clinical Study published in Journal of physiology and biochemistry. Key conclusion: A significant challenge lies in managing autoimmune disorders with unknown origins that stem from the reactivation of the immune system.
View Original PubMed Abstract ↓

Since its introduction in 2012, ferroptosis has garnered significant attention from researchers over the past decade. Unlike autophagy and apoptosis, ferroptosis is an atypical iron-dependent programmed cell death that falls under necrosis. It is regulated by various cellular metabolic and signaling processes, which encompass amino acid, lipid, iron, and mitochondrial metabolism. The initiation of ferroptosis occurs through iron-dependent phospholipid peroxidation. Notably, ferroptosis exhibits a dual effect and is associated with various diseases. A significant challenge lies in managing autoimmune disorders with unknown origins that stem from the reactivation of the immune system. Two contributing factors to autoimmunity are the aberrant stimulation of cell death and the inadequate clearance of dead cells, which can expose or release intracellular components that activate the immune response. Ferroptosis is distinct from other forms of cell death, such as apoptosis, necroptosis, autophagy, and pyroptosis, due to its unique morphological, biochemical, and genetic characteristics and specific relationship with cellular iron levels. Recent studies indicate that immune cells can both induce and undergo ferroptosis. To better understand how ferroptosis influences immune responses and its imbalance in disease, a molecular understanding of the relationship between ferroptosis and immunity is essential. Consequently, further research is needed to develop immunotherapeutics that target ferroptosis. This review primarily focuses on the role of ferroptosis in immune-related disorders. © 2025. The Author(s) under exclusive licence to University of Navarra.

04
CLINICAL STUDY Pathology, research and practice (2025) PMID: 40037052 ↗
Study of toxic and essential elemental imbalances at more advance stage of breast carcinoma patients.
Clinical Trial Synthesis 2025 Clinical Study published in Pathology, research and practice involving n = 161 participants; statistical significance reported at p = 0.05. Key conclusion: Overall, the current study indicates a potential role of toxic trace elements in the development of breast carcinoma and these findings could be significant in the predicting diagnosis/prognosis of breast malignancy.
View Original PubMed Abstract ↓

Erratum in Pathol Res Pract. 2025 Jun;270:156000. doi: 10.1016/j.prp.2025.156000. Delayed diagnosis and limited access to healthcare resources are leading to advanced stage breast carcinoma posing a formidable health challenge to modern medical science. Avoiding the occurrence of breast carcinoma is only possible by ascertaining the risk factors contributing to the progression of this fatal malignancy. Among other factors, exposure to trace elements plays a decisive role in progression of breast carcinoma development. The purpose of this investigation was to evaluate the harmful traces and vital components (Pb, Ca, Mn, Cd, Na, Cr, Cu, Mg, Sr, K, Fe, Zn, Co, Li, Se, Ag, Hg, As, Al and Ni) contents in the blood (n = 161), scalp hair (n = 149) and nails (n = 135) of stage IV breast carcinoma patients and female controls by atomic absorption spectrometry. The results revealed that mean Cr, Cu, Pb and Cd levels were elevated significantly (p < 0.05) in the nails and blood, while Ni, Co, Cr, Pb and Cd levels (p < 0.05) were elevated in the scalp hair of stage IV breast carcinoma patients than the female controls. Based on pathological breast cancer types, Pb and Cd were elevated in invasive ductal carcinoma, while Cu and Co were higher in invasive lobular carcinoma patients. Multivariate analysis was applied for the source of identification and apportionment of toxic trace elements in both donor groups. Most of the factors showed significant differences between the malignant and control groups' dietary, housing, and tobacco use/nonuse behaviors. The correlation analysis revealed significantly different association patterns for toxic trace elements in patients and controls and has an influential effect on cancer risk. Overall, the current study indicates a potential role of toxic trace elements in the development of breast carcinoma and these findings could be significant in the predicting diagnosis/prognosis of breast malignancy.

05
CLINICAL STUDY Toxicologic pathology (2017) PMID: 28580887 ↗
Titanium Nanoparticle Size Influences Trace Concentration Levels in Skin Appendages.
Clinical Trial Synthesis 2017 Clinical Study published in Toxicologic pathology. Key conclusion: Given that the nails showed the highest levels of Ti, and that these skin appendages are not exposed to agents that can leach out Ti, as occurs with hair, we propose the nails as the most suitable and reliable bioindicator for monitoring systemic contamination with Ti.
View Original PubMed Abstract ↓

As a result of biotribocorrosion, the surface of a titanium (Ti) biomedical device can be a potential source of systemic contamination with Ti nanoparticles (NPs). Although NPs can be chemically similar, differences in particle size may lead to different biological responses. The aim of this experimental study was to determine Ti trace levels in skin appendages and plasma and explore the influence of NP size on trace levels using a murine model. Results showed the presence of Ti traces in the nails, hair, and plasma. The concentration of the smallest NPs (5 Nm) was higher than that of 10 Nm NPs in all the studied samples. Irrespective of NP size, Ti levels were always lower in plasma than in skin appendages. Ti levels were higher in nails than in hair. Ti NPs size influenced trace concentration levels in hair/nails, suggesting that 5 Nm Ti particles are more easily eliminated through these skin appendages. Given that the nails showed the highest levels of Ti, and that these skin appendages are not exposed to agents that can leach out Ti, as occurs with hair, we propose the nails as the most suitable and reliable bioindicator for monitoring systemic contamination with Ti.

06
CLINICAL STUDY Journal of multidisciplinary healthcare (2025) PMID: 41488437 ↗
Mobile Health Clinics and Telehealth Outreach in Thailand: A Focus on Elderly Care and NCDs.
Clinical Trial Synthesis 2025 Clinical Study published in Journal of multidisciplinary healthcare involving n = 300 participants (OR 3.95). Key conclusion: The National Health Security Office (NHSO) introduced a nationwide telemedicine service under the Universal Coverage Scheme, enabling remote consultations and medication deliveries for stable chronic NCD patients, ensuring continuity of care during lockdowns.
View Original PubMed Abstract ↓

BACKGROUND: Thailand faces a rapidly aging population alongside a high burden of non-communicable diseases (NCDs). Ensuring equitable healthcare access for older adults with NCDs is a pressing challenge. Mobile health clinics and telehealth services have emerged as key strategies to reach underserved elderly populations and maintain continuity of NCD care in remote or resource-limited settings. OBJECTIVE: To examine current mobile clinic initiatives and telehealth outreach in Thailand focused on elderly care and NCD management, and to evaluate their impact on healthcare access and outcomes for older adults. METHODS: We conducted a narrative review of published literature, policy reports, and program descriptions on mobile health clinics and telehealth interventions in Thailand, with emphasis on applications for older adults and chronic disease care (eg, diabetes, hypertension). A comprehensive search (2010-2025) of PubMed, Google Scholar, and Thai government/organization websites identified relevant sources. Data on intervention models, settings, target populations, and reported outcomes were extracted. In total, 15 key publications and reports were reviewed, from which 8 major mobile clinic or telehealth initiatives were identified. RESULTS: Mobile health clinics have expanded primary care access for vulnerable elderly in both urban and rural areas. The Thai Red Cross Society's mobile clinic serves remote mountainous communities and provides primary care, NCD screenings, vaccinations, and medications to about 5,000 underserved people annually. Past mobile outreach programs have uncovered many untreated cases-in one survey, 58% of hypertensive and 75% of diabetic elderly were first diagnosed via a mobile unit. Telehealth services have likewise grown substantially. During the COVID-19 pandemic, telemedicine was rapidly adopted for routine consultations and chronic disease follow-ups. The National Health Security Office (NHSO) introduced a nationwide telemedicine service under the Universal Coverage Scheme, enabling remote consultations and medication deliveries for stable chronic NCD patients, ensuring continuity of care during lockdowns. Numerous telehealth appl

07
CLINICAL STUDY Analytica chimica acta (2025) PMID: 41093503 ↗
Engineered methionine-functionalized magnetic nanobiocomposites for precision biomonitoring of petroleum-driven heavy metal contamination in occupational and environmental health.
Clinical Trial Synthesis 2025 Clinical Study published in Analytica chimica acta; statistical significance reported at p = 0.05. Key conclusion: In contrast, endogenous Cu (7.8-11.2 mg/kg), Zn (110-165 mg/kg), and Fe (12.3-28.1 mg/kg) levels showed no significant inter-cohort differences, confirming metabolic regulation over exogenous input.
View Original PubMed Abstract ↓

BACKGROUND: Environmental biomonitoring of petroleum-linked heavy metal exposure remains challenging due to limitations in sensitivity, selectivity, and matrix complexity of conventional methods. This study bridges this gap by engineering methionine-functionalized magnetic nanoparticles (Fe3O4@SiO2@CPTES@Methionine) for precision monitoring. Leveraging methionine's dual-function groups, the nanoplatform selectively preconcentrates trace lead (Pb) and cadmium (Cd) from human hair/nails prior to AAS quantification. This approach specifically targets exogenous contamination from petroleum activities, distinguishing it from endogenous elements (Cu, Zn, Fe). The method enables direct linkage of industrial pollution to human exposure, addressing critical needs in occupational/environmental health. RESULTS: The nanobiocomposite achieved ultra-trace detection limits (0.003-0.03 mg/kg) and high recovery (>95 %) across all target metals, validated using certified reference materials (98-102 % recovery). Analysis revealed significantly elevated Pb (0.8-3.0 mg/kg) and Cd (0.2-0.6 mg/kg; p < 0.05) accumulation in oil field workers compared to non-exposed controls (Pb: 0.1-0.5 mg/kg; Cd: 0.03-0.1 mg/kg), directly implicating petroleum operations. In contrast, endogenous Cu (7.8-11.2 mg/kg), Zn (110-165 mg/kg), and Fe (12.3-28.1 mg/kg) levels showed no significant inter-cohort differences, confirming metabolic regulation over exogenous input. The nanoplatform demonstrated reusability (>3 cycles) without performance loss. SIGNIFICANCE: This work establishes a transformative, nanotechnology-enabled biomonitoring tool that precisely links petroleum-driven heavy metal contamination to human exposure. Its high sensitivity, selectivity, and reusability offer a scalable strategy for real-time occupational risk assessment, pollution source tracking, and environmental health management in resource-extraction zones. The methodology bridges advanced material design with practical global health applications, providing a definitive tool for exposure attribution and supporting ecological sustainability.

08
CLINICAL STUDY Frontiers in nutrition (2022) PMID: 36726817 ↗
Recent advances in the application of ionomics in metabolic diseases.
Clinical Trial Synthesis 2022 Clinical Study published in Frontiers in nutrition. Key conclusion: Overall, ionomics not only improves our understanding of the association between elemental dyshomeostasis and the development of metabolic disease but also assists in the identification of new potential diagnostic and prognostic markers in translational medicine.
View Original PubMed Abstract ↓

Trace elements and minerals play a significant role in human health and diseases. In recent years, ionomics has been rapidly and widely applied to explore the distribution, regulation, and crosstalk of different elements in various physiological and pathological processes. On the basis of multi-elemental analytical techniques and bioinformatics methods, it is possible to elucidate the relationship between the metabolism and homeostasis of diverse elements and common diseases. The current review aims to provide an overview of recent advances in the application of ionomics in metabolic disease research. We mainly focuses on the studies about ionomic or multi-elemental profiling of different biological samples for several major types of metabolic diseases, such as diabetes mellitus, obesity, and metabolic syndrome, which reveal distinct and dynamic patterns of ion contents and their potential benefits in the detection and prognosis of these illnesses. Accumulation of copper, selenium, and environmental toxic metals as well as deficiency of zinc and magnesium appear to be the most significant risk factors for the majority of metabolic diseases, suggesting that imbalance of these elements may be involved in the pathogenesis of these diseases. Moreover, each type of metabolic diseases has shown a relatively unique distribution of ions in biofluids and hair/nails from patients, which might serve as potential indicators for the respective disease. Overall, ionomics not only improves our understanding of the association between elemental dyshomeostasis and the development of metabolic disease but also assists in the identification of new potential diagnostic and prognostic markers in translational medicine.

09
CLINICAL STUDY Metallomics (2022) PMID: 35648480 ↗
Recent advances in the application of metallomics in diagnosis and prognosis of human cancer.
Clinical Trial Synthesis 2022 Clinical Study published in Metallomics. Key conclusion: Elevated levels of copper appear to be a significant risk factor for various cancers, and each type of cancer has a unique distribution of metals in biofluids, hair/nails, and tumor-affected tissues.
View Original PubMed Abstract ↓

Metals play a critical role in human health and diseases. In recent years, metallomics has been introduced and extensively applied to investigate the distribution, regulation, function, and crosstalk of metal(loid) ions in various physiological and pathological processes. Based on high-throughput multielemental analytical techniques and bioinformatics methods, it is possible to elucidate the correlation between the metabolism and homeostasis of diverse metals and complex diseases, in particular for cancer. This review aims to provide an overview of recent progress made in the application of metallomics in cancer research. We mainly focuses on the studies about metallomic profiling of different human biological samples for several major types of cancer, which reveal distinct and dynamic patterns of metal ion contents and the potential benefits of using such information in the detection and prognosis of these malignancies. Elevated levels of copper appear to be a significant risk factor for various cancers, and each type of cancer has a unique distribution of metals in biofluids, hair/nails, and tumor-affected tissues. Furthermore, associations between genetic variations in representative metalloprotein genes and cancer susceptibility have also been demonstrated. Overall, metallomics not only offers a better understanding of the relationship between metal dyshomeostasis and the development of cancer but also facilitates the discovery of new diagnostic and prognostic markers for cancer translational medicine. © Oxford University Press 2022.

10
CLINICAL STUDY Environmental geochemistry and health (2020) PMID: 31317372 ↗
Using human hair and nails as biomarkers to assess exposure of potentially harmful elements to populations living near mine waste dumps.
Clinical Trial Synthesis 2020 Clinical Study published in Environmental geochemistry and health. Key conclusion: Whilst for toenails the decreasing order of mean concentrations was Zn (172 ± 27 mg/kg), Cu (30 ± 5 mg/kg), Mn (12 ± 2 mg/kg), Pb (4.8 ± 0.5 mg/kg), Ni (1.7 ± 0.14 mg/kg) and Co (1.0 ± 0.02 mg/kg), Cr (0.6 ± 0.1 mg/kg) and Cd (0.1 ± 0.002 mg/kg).
View Original PubMed Abstract ↓

Potentially harmful elements (PHEs) manganese (Mn), cobalt (Co), copper (Cu), lead (Pb), nickel (Ni) and zinc (Zn) were measured in human hair/nails, staple crops and drinking water to ascertain the level of exposure to dust transference via wind and rain erosion for members of the Mugala community living near a mine waste dump in the Zambian Copperbelt. The mean PHE concentrations of hair in decreasing order were Zn (137 ± 21 mg/kg), Cu (38 ± 7 mg/kg), Mn (16 ± 2 mg/kg), Pb (4.3 ± 1.9 mg/kg), Ni (1.3 ± 0.2 mg/kg) and Cr (1.2 ± 0.2 mg/kg), Co (0.9 ± 0.2 mg/kg) and Cd (0.30 ± 0.02 mg/kg). Whilst for toenails the decreasing order of mean concentrations was Zn (172 ± 27 mg/kg), Cu (30 ± 5 mg/kg), Mn (12 ± 2 mg/kg), Pb (4.8 ± 0.5 mg/kg), Ni (1.7 ± 0.14 mg/kg) and Co (1.0 ± 0.02 mg/kg), Cr (0.6 ± 0.1 mg/kg) and Cd (0.1 ± 0.002 mg/kg). The concentration of these potentially harmful elements (PHEs) varied greatly among different age groups. The results showed that Mn, Co, Pb, Cd and Zn were above the interval values (Biolab in Nutritional and environmental medicine, Hair Mineral Analysis, London, 2012) at 0.2-2.0 mg/kg for Mn, 0.01-0.20 mg/kg for Co, < 2.00 mg/kg for Pb, < 0.10 mg/kg for Cd and 0.2-2.00 mg/kg for Zn, whilst Ni, Cu and Cr concentrations were within the normal range concentrations of < 1.40 mg/kg, 10-100 mg/kg and 0.1-1.5 mg/kg, respectively. Dietary intake of PHEs was assessed from the ingestion of vegetables grown in Mugala village, with estimated PHE intakes expressed on a daily basis calculated for Mn (255), Pb (48), Ni (149) and Cd (33) µg/kg bw/day. For these metals, DI via vegetables was above the proposed limits of the provisional tolerable daily intakes (PTDIs) (WHO in Evaluation of certain food additive and contaminants, Seventy-third report of the Joint FAO/WHO Expert Committee on Food Additives, 2011) for Mn at 70 µg/kg bw/day, Pb at 3 µg/kg bw/day, Ni and Cd 5 µg/kg bw/day and 1 µg/kg bw/day, respectively. The rest of the PHEs listed were within the PTDIs limits. Therefore, Mugala inhabitants are at imminent health risk due to lead, nickel and cadmium ingestion of vegetables and drinking water at this location.

RELATED MONOGRAPHS

Related Monographs in This Category